Ignite Creation Date:
2024-05-05 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00221780
Status:
UNKNOWN
Last Update Posted:
2007-06-29
First Post:
2005-09-13
Brief Title:
Role of Left Ventricular Pacing Site
Sponsor:
University Hospital Bordeaux
Organization:
University Hospital Bordeaux
Study Overview
Official Title:
Importance of Left Ventricular Pacing Site in Biventricular Resynchronization Therapy for Severe Heart Failure
Status:
UNKNOWN
Status Verified Date:
2007-06
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Cardiac resynchronization therapy has been shown to be effective in reducing symptoms and mortality in heart failure patients However very few is known about the importance of the left ventricular pacing site We study in a random order 11 different left ventricular pacing sites and compare their hemodynamics using pressure-volume catheters The consequences on the surface ECG are also assessed
Detailed Description:
Background Cardiac resynchronization therapy has been shown to be effective in reducing symptoms and mortality in heart failure patients However very few is known about the importance of the left ventricular pacing site
Design Single-blind monocentric randomized cross-over study comparing 11 left ventricular pacing sites in a random order
Intervention Left ventricular DDD pacing on 11 ventricular sites prior to the implantation At each pacing site a control hemodynamics will be obtained in AAI pacing at the same pacing rate At each pacing site 2 AV delays a short and a long one will be assessed
Eligibility criteria Patients referred for cardiac resynchronization therapy for heart failure
Outcomes Hemodynamic measures using pressure-volume catheters
Design Single-blind monocentric randomized cross-over study comparing 11 left ventricular pacing sites in a random order
Intervention Left ventricular DDD pacing on 11 ventricular sites prior to the implantation At each pacing site a control hemodynamics will be obtained in AAI pacing at the same pacing rate At each pacing site 2 AV delays a short and a long one will be assessed
Eligibility criteria Patients referred for cardiac resynchronization therapy for heart failure
Outcomes Hemodynamic measures using pressure-volume catheters
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2001-030 | None | None | None |